| On ART | Not on ART | P-value at α = 0.05* | P-value at α = 0.00625§ |
---|
| Median (IQR) | Median (IQR) |
---|
IL-6 | 3092 | [540, 9366] | 763 | [381, 1813] | 0.124 | 0.124 |
IFN-g | 1410 | [784, 3230] | 453 | [154, 753] | 0.115 | 0.115 |
GM-CSF | 1893 | [1632, 1975] | 1791 | [1451, 1890] | 0.002* | 0.002§ |
TNF-a | 95 | [61, 299] | 79 | [6, 136] | 0.255 | 0.255 |
IL-2 | 98 | [33, 223] | 64 | [25, 127] | 0.530 | 0.530 |
IL-4 | 32 | [9, 77] | 9 | [9, 26] | 0.245 | 0.245 |
IL-8 | 1364 | [419, 2573] | 443 | [389, 585] | 0.021* | 0.021 |
IL-10 | 273 | [232, 497] | 215 | [184, 292] | 0.000* | 0.000§ |
- *Significant at α = 0.05
- §Significant at α = 0.00625 corrected with Bonferroni correction for multiple comparisons
- Pro-inflammatory cytokine (GM-CSF, IL-8 and IL-10) were found at significantly higher levels among HIV patients on ART
- IL-6 Interleukin 6, IFN-g Interferon –gamma, GM-CSF Granulocyte macrophage colony stimulating factor, TNF-a Tumour necrosis factor alpha, IL-2 Interleukin 2, IL-4 Interleukin 4, IL-8 Interleukin 8, IL 10 Interleukin 10, IQR Interquartile range, RHSP Rakai Health Service Programme, ART Antiretroviral therapy (zidovudine, lamivudine and nevirapine)